Regulating (or not) reproductive medicine: an alternative to letting the market decide

Indian J Med Ethics. Jul-Sep 2011;8(3):175-9. doi: 10.20529/IJME.2011.068.


Whilst India has been debating how to regulate 'surrogacy' the UK has undergone a major consultation on increasing the amount of 'expenses'paid to egg 'donors', while France has recently finished debating its entire package of bioethics regulation and the role of its Biomedicine Agency. Although it is often claimed that there is no alternative to the neo-liberal, market-based approach in regulating (or not) reproductive medicine--the ideology prevalent in both India and the UK--advocates of that position ignore the alternative model offered by France's tighter regulation, as well as its overarching concern with protecting the vulnerable and ensuring social justice. Whilst the concepts underpinning the French model of regulation also have their provenance in Western political philosophy and not in the developed world, they embody a very different attitude and suggest that there is indeed an alternative to letting the market decide. However, even in France that alternative is highly contested.

MeSH terms

  • France
  • Humans
  • Ovum
  • Public Policy*
  • Remuneration*
  • Reproductive Techniques, Assisted / economics*
  • Reproductive Techniques, Assisted / ethics
  • Reproductive Techniques, Assisted / legislation & jurisprudence*
  • Social Control, Formal / methods*
  • Tissue Donors / ethics
  • Tissue Donors / legislation & jurisprudence
  • Tissue and Organ Procurement / economics*
  • Tissue and Organ Procurement / ethics
  • Tissue and Organ Procurement / legislation & jurisprudence*
  • United Kingdom